ticularly dramatic reductions are seen in their neurovirulence. Furthermore, these viruses appear to be unable to reactivate from latent infections and therefore they would be unlikely to cause recurrent disease, and transmission would likely be reduced or eliminated. Resistance may also be acquire
โฆ LIBER โฆ
Disease and latency characteristics of clinical herpes simplex virus isolates after acyclovir therapy
โ Scribed by Cornelia D. Sibrack; Colin McLaren; David W. Barry
- Book ID
- 115678916
- Publisher
- Elsevier Science
- Year
- 1982
- Tongue
- English
- Weight
- 500 KB
- Volume
- 73
- Category
- Article
- ISSN
- 1555-7162
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Sensitivity monitoring of clinical isola
โ
Dr. P. Collins; M. Nixon Ellis
๐
Article
๐
1993
๐
John Wiley and Sons
๐
English
โ 727 KB
Molecular analysis of clinical isolates
โ
Doris Chibo; Julian Druce; Joe Sasadeusz; Chris Birch
๐
Article
๐
2004
๐
Elsevier Science
๐
English
โ 142 KB
Spectrum of sensitivity to acyclovir of
โ
Colin McLaren; Cornelia D. Sibrack; David W. Barry
๐
Article
๐
1982
๐
Elsevier Science
๐
English
โ 434 KB
Phenotypic and genotypic characterizatio
โ
A. Sauerbrei; S. Deinhardt; R. Zell; P. Wutzler
๐
Article
๐
2010
๐
Elsevier Science
๐
English
โ 210 KB
Rapid screening of clinical herpes simpl
โ
D.G. Ketchum; R.S. Gohd; E.D. Starszak; R.B. Van Dyke
๐
Article
๐
1991
๐
Elsevier Science
๐
English
โ 72 KB
Recurrent herpes simplex virus hepatitis
โ
Thomas Longerich; Christoph Eisenbach; Roland Penzel; Thomas Kremer; Christa Fle
๐
Article
๐
2005
๐
John Wiley and Sons
๐
English
โ 267 KB
Herpes virus hepatitis (HSV) represents a form of acute necrotizing hepatitis, which most frequently develops in immunocompromised patients. Therapeutic options include high-dose intravenous acyclovir and liver transplantation. We report the first case of recurrent HSV hepatitis after liver retransp